Skip to main content
. 2018 Jan 3;9(18):14124–14137. doi: 10.18632/oncotarget.23897

Figure 6. ADR resistant effects caused by JNJ occur in other cancers.

Figure 6

(A) The temporal RNA expression levels of XIAP, c-Fos and c-Jun were measured by quantitative real time PCR in HepG2 cells after JNJ treatment. (B) The expression of AP-1 was measured by western blot in HepG2 cells after JNJ treatment. (C) The temporal protein expression of XIAP, AP-1, c-Fos and c-Jun were measured by western blot in HepG2 cells after JNJ treatment.